Antihypertensive medication classes and the risk of dementia over a decade of follow-up
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Hypertension"
DOI: 10.1097/hjh.0000000000003324
Abstract: Introduction: Use of angiotensin II (ATII)-stimulating antihypertensive medication (AHM), including angiotensin receptor blockers (ARBs) and dihydropyridine calcium channel blockers (CCBs), has been associated with lower dementia risk. Previous studies had relatively short follow-up periods. The… read more here.
Keywords: lower dementia; antihypertensive medication; hazard ratio; atii stimulating ... See more keywords